ConvaTec

Greensboro, United States Founded: 1977 • Age: 49 yrs Acquired By Avista Capital Partners
Portfolio of wound care, ostomy care, stomacare, fecal management

About ConvaTec

ConvaTec is a Healthcare company based in Greensboro (United States) founded in 1977, and was acquired by Avista Capital Partners in August 2008. Portfolio of wound care, ostomy care, stomacare, fecal management. ConvaTec has completed 3 acquisitions, including 180Medical, AbViser Medical and Unomedical. Its chief executive, as recorded, is Karim Bitar. Its website convatec.com draws about 259 thousand monthly visits. Its Indian entity Convatec India Private Limited reported revenue of ₹5.4 Lakh. Its focus areas include Life Sciences, Wound Care, Medical Devices and Therapeutic Devices. Its competitors include Medtronic, GE Healthcare and Boston Scientific; 1 of its 3 listed competitors has raised funding.

Company details

ConvaTec Limited develops, manufactures, and markets products for wound therapeutics, ostomy care, stomacare, skin care, and fecal management. Its products are targeted at patients as well as health care professionals. The company makes wound cleansers, dressings, bandages, wound hydration products, and a negative pressure wound therapy system. Its products are designed to improve the management and healing of wounds and address such issues as wound dryness and severity. ConvaTecs additional products include ostomy pouches that allow patients with artificial openings (or stomas) to dispose of bodily waste into attachable pouches. It also makes continence, critical care, and infusion products. Convatec is owned by private equity firms Avista Capital Partners and Nordic Capital who bought it from Bristol-Myers-Squibb in 2008 for 4.1B

Key Metrics

Apps and channels of ConvaTec

its YouTube channel Convatec Canada has 908 subscribers and 30 videos.

Convatec Canada
YouTube 908 subscribers 30 videos Science & Technology
Open channel

Videos from ConvaTec

The most watched videos on ConvaTec's YouTube channel, Convatec Canada (908 subscribers). Click a video to play it here.

Comment appliquer et retirer un pansement Aquacelᴹᴰ Ag Surgical (césarienne)
13.4K views
How to Apply and Remove Aquacel® Ag+ Extra Dressings (Pressure Ulcer Category 3)
8.5K views
How to Apply and Remove Aquacel® Ag Foam Dressings (Venous Leg Ulcer)
7.2K views
Comment appliquer et retirer un pansement mèche Aquacelᴹᴰ Ag+ (plaie cavitaire)
6.8K views

More on Convatec Canada.

Funding Insights of ConvaTec

  • Total Rounds 14
  • Last Round Grant — $124,367
  • First Round $745M

    (Dec 2010)

  • Investors Count 1

Latest 10 of 14 funding rounds of ConvaTec with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2024$124,367Grant––
Mar 2024$126,509Grant––
Feb 2024$5,427Grant––
Dec 2023$126,140Grant––
Dec 2023$284,928Grant––
Oct 2023$113,218Grant––
Aug 2023$206,420Grant––
Jul 2023$206,450Grant––
Jun 2023$197,160Grant––
May 2023$216,383Grant––
Valuation history

3 investors in total: 3 institutional.

Investors in ConvaTec

ConvaTec has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Ministerstvo Hospodárstva Slovenskej Republiky, Avista Capital Partners and Nordic Capital.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
nordiccapital.com
mhsr.sk
Private equity investments are focused on the United States market.
avistacap.comNew York, United States
Premium access

Investor details for ConvaTec

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Convatec India Private Limited (ConvaTec)

Convatec India Private Limited is the primary company behind ConvaTec. The board of Convatec India Private Limited currently have 3 directors; the longest-serving is Tiago Rafael Cosmo, appointed in 2023. 25 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Tiago Rafael Cosmo
DIN 10118842
Director18 Apr 20233 yrs 6 moConvatec India Private Limited
Harshal Goswami
DIN 10668684
Director25 Jun 20242 yrs 4 moConvatec India Private Limited
Rajesh Babu
DIN 08971032
Additional Director18 Jun 20251 yr 4 moConvatec India Private Limited

People of ConvaTec

634 people are tracked at ConvaTec (217 in leadership, 5 in board & advisors, 412 in team).

NameRoleGroup
Karim Bitar
CEOLeadership
Anne Belcher
President & COO, Global Emerging MarketsLeadership
Bruno Pinheiro
President & COO, Ostomy CareLeadership
Giulia Cherbavaz
Global Corporate Affairs Business Partner - ChannelsLeadership
Michael Mandarano
Director Of Application DevelopmentLeadership
Divakar Ramakrishnan
EVP & Chief Technology OfficerLeadership
Sonny Lyngsø
VP Finance, Global Quality, Operations & RegulatoryLeadership
Joanne Bellass
Associate Quality DirectorLeadership
Aimee Brenes
Sr. Director Of QualityLeadership
Jared Ragone
Sr. Director Quality Management Systems And Quality ComplianceLeadership
Chris Arnold
Vp, IMLeadership
Stephanie Tomlinson
Head IT PMOLeadership
Gary Holder
Vice President - Corporate Accounts & Channel ManagementLeadership
April Brinson-Carrano
Associate Director, Benefits US & CanadaLeadership
Cassie Hong
Associate Director, HRBPLeadership
Raina Bhushan (Mba
Digital Portfolio DirectorLeadership
Jonny Mason
CFO & DirectorLeadership
Evelyn Douglas
EVP, Chief of Corporate Strategy & Business DevelopmentLeadership
Kjersti Grimsrud
President & COO, Infusion CareLeadership
John Haller
EVP & Chief Quality & Operations OfficerLeadership

614 more people are available in the full profile.

Premium access

Complete people profiles for ConvaTec

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of ConvaTec

Figures of Convatec India Private Limited, the primary company behind ConvaTec, for FY 2022. Revenue was ₹5.4 Lakh. Net loss was -₹40,290 (-7% margin). EBITDA was -₹35,319 (-6% margin).

  • ₹5.4 LakhRevenue · FY 2022
  • -₹40,290Net loss · -7% margin
  • -₹35,319EBITDA · -6% margin
  • ₹34.41 CrPaid-up capital
  • 61Employees (provident fund records)

Balance sheet, profit and loss, cash flow and ratios of Convatec India Private Limited are on its company page.

Premium access

Detailed financial statements for ConvaTec

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by ConvaTec

ConvaTec has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include 180Medical, AbViser Medical and Unomedical.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Urinary catheters and ostomy equipment are supplied nationwide.
180medical.comOklahoma, United States2009Aug 2012$321M
Healthcare monitoring services are provided by AbViser Medical.
abviser.comSalt Lake, United States2010May 2012••••
Insulin infusion sets with 90-degree insertion angle
unomedical.comRudersdal, Denmark1964Sep 2008••••
Premium access

Complete acquisition details for ConvaTec

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of ConvaTec

7 dated milestones of ConvaTec across 47 years, from founding to its latest funding, stage changes and deals.

  1. Founded ConvaTec is founded.
  2. Exit Acquired by Avista Capital Partners.
  3. Acquisition Acquires Unomedical.
  4. Funding First funding round of $745.0M.
  5. Acquisition Acquires AbViser Medical.
  6. Acquisition Acquires 180Medical.
  7. Funding Latest funding round, Grant, of $124K.

Competitors of ConvaTec

ConvaTec has 3 listed competitors in our database, 1 of them funded. They include Medtronic, GE Healthcare and Boston Scientific.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
medtronic.com1949Minneapolis, United States1,114
Medical equipment for treating over 30 chronic diseases is developed.
gehealthcare.com1892Chicago, United States$29.13M16,700
Materials management solutions are provided for healthcare organizations.
bostonscientific.com1979Marlborough, United States63,359
Wide range of medical devices
Premium access

Detailed competitors of ConvaTec

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of ConvaTec

The website of ConvaTec (convatec.com) receives about 258.8K visits a month and ranks #193,008 among all websites worldwide, #6,228 in Health.

  • Monthly visits
    258.8K

    ▲ 9.7% vs previous month

  • Unique visitors
    110.4K

    per month

  • Global rank
    #193,008

    among all websites

  • Category rank
    #6,228

    Health · Health

Similar websites

Websites whose visitors overlap most with ConvaTec. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
dermasciences.com
100%
View details
smith-nephew.com
95%
296.7K#152,630View details
wocn.org
wocn.org
94%
#670,616–
marlenmfg.com
87%
#3,818,754View details
coloplast.com
82%
155.3K#298,292View details
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 40 similar websites and full traffic analytics for ConvaTec

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Wound Care

3 companies that operate in the same segment as ConvaTec (Wound Care) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Nanotech-based wound care products are developed and provided.
2010Madison, Wisconsin, United StatesUSD 22.7 M35
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics
1985Marietta, Georgia, United StatesUSD 418.63 M837
Developer of hemostatic products for wound care
2010New York, New York, United StatesUSD 113.35 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Convatec

Premium access

Complete news archive for ConvaTec

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about ConvaTec

ConvaTec was founded in 1977 and raised its 1st funding round 33 years after it was founded.

ConvaTec is headquartered in Greensboro, United States. It is registered at Greensboro, North Carolina, United States.

Karim Bitar is the CEO of ConvaTec, as recorded in our data.

The primary company behind ConvaTec, Convatec India Private Limited, reported revenue of ₹5.4 Lakh for FY 2022.

ConvaTec Limited develops, manufactures, and markets products for wound therapeutics, ostomy care, stomacare, skin care, and fecal management. Its products are targeted at patients as well as health care professionals. The company makes wound cleansers, dressings, bandages, wound hydration products, and a negative pressure wound therapy system. Its products are designed to improve the management and healing of wounds and address such issues as wound dryness and severity. ConvaTecs additional products include ostomy pouches that allow patients with artificial openings (or stomas) to dispose of bodily waste into attachable pouches. It also makes continence, critical care, and infusion products. Convatec is owned by private equity firms Avista Capital Partners and Nordic Capital who bought it from Bristol-Myers-Squibb in 2008 for 4.1B.

ConvaTec's top competitors include GE Healthcare, Medtronic and Boston Scientific.

ConvaTec has made 3 acquisitions, including 180Medical, AbViser Medical, and Unomedical.

ConvaTec has 3 investors. Key investors include Ministerstvo Hospodárstva Slovenskej Republiky, Avista Capital Partners, and Nordic Capital.

ConvaTec operates through Convatec India Private Limited.

Yes. ConvaTec was acquired by Avista Capital Partners in August 2008.

The legal entities of ConvaTec currently have 4 directors, including Rajesh Babu, Harshal Goswami, Tiago Rafael Cosmo and others.

The website of ConvaTec receives about 259 thousand visits a month and ranks #193,008 among all websites worldwide.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available